Institute of Clinical Research wins injunction against rivalFebruary 16th, 2008 - 10:44 pm ICT by admin
Mumbai, Feb 16 (IANS) The Institute of Clinical Research India (ICRI), India’s premier institution in clinical research studies, has obtained an injunction from the Delhi High Court, restraining Clinical Research Institute (CRI) from using this name. According to a release issued by ICRI, the court in its order stated: “The defendant is restrained from using the trademark CRI or the name Clinical Research Institute (India) in connection with its business activities.”
ICRI approached the Delhi High Court demanding a permanent injunction against Vijay Moza, founder of CRI, from using the mark and name as it has violated the trademark of ICRI.
ICRI currently operates from four campuses in Mumbai, Delhi, Ahmedabad and Bangalore.
Tags: ahmedabad, bangalore, business activities, campuses, clinical research institute, clinical research studies, cri, defendant, delhi high court, icri india, injunction against, institute of clinical research, institute of clinical research india, mumbai delhi, permanent injunction